Claudin‐2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences

BACKGROUND: Predicting any future metastatic site of early‐stage breast cancer is important as it significantly influences the prognosis of advanced disease. This study aimed at investigating the potential of claudin‐2, over‐expressed in breast cancer liver metastases, as a biomarker for predicting...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Oncol
Autors principals: Kimbung, Siker, Kovács, Anikó, Bendahl, Pär-Ola, Malmström, Per, Fernö, Mårten, Hatschek, Thomas, Hedenfalk, Ingrid
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2013
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528500/
https://ncbi.nlm.nih.gov/pubmed/24287398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2013.10.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars